ArticleJournal for immunotherapy of cancer2022

DuoBody-CD40x4-1BB induces dendritic-cell maturation and enhances T-cell activation through conditional CD40 and 4-1BB agonist activity.

Alexander Muik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.